1 / 7

Antidiabetics Market to grow at 10.5% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2t2aMfX <br>Rising diabetes incidences, large unmet medical needs, and extensive R&D activities to launch new antidiabetic drugs including Glucagon like peptide 1 (GLP-1) agonist and Dipeptidyl peptidase - IV will promote other antidiabetics market growth.

jueekate
Download Presentation

Antidiabetics Market to grow at 10.5% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antidiabetics Market share to witness growth of 10.5% from 2017 to 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Antidiabetics Market : • Antidiabetics Market growth is driven by rising geriatric population base, innovation of new drugs, increasing adoption of drugs and increased disposable income. • Antidiabetics Market size is set to reach USD 110 billion by 2024; according to a new research report by Global Market Insights, Inc. • Increasing number of obese and diabetic patients coupled with rising patient awareness levels serve as high impact rendering factors for antidiabetic market growth over the forecast period. • Favorable government initiatives such as Diabetes Prevention Program (DPP) that aims to help individuals with prediabetes, reduces their risk to develop type 2 diabetes. • Basal insulin suppresses hepatic gluconeogenesis and prevent increase in glucose level during fasting state in insulin-deficient patients. • Biguanides should contribute for significant revenue share in 2016. It is colorless solid and prevents production of glucose in liver.

  3. Continued... • It helps in improving sensitivity of body towards insulin and decreases amount of sugar absorbed in intestines and will increase demand for such antidiabetic drugs. • U.S. antidiabetics market size valued over USD 19.4 billion in 2016 and expected to grow significantly over the coming years. • UK contributed for significant revenue share in 2016. The growth is attributed due to wide range of funds offered by Diabetes UK for research related to the treatment of diabetes and its complications. • Japan antidiabetics market should grow at significant rate over the forecast period. Diabetic population is on rise due to lifestyle changes that will accompany economic growth and drive antidiabetic market growth. • Some of the companies operating in antidiabetics market include Eli Lilly, Pfizer, Novo Nordisk, Takeda Pharmaceuticals, Sanofi Aventis, Merck, Boehringer Ingelheim and Oramed Pharmaceuticals.

  4. India Antidiabetics Market, By Product, 2013 - 2024 (USD Million)

  5. Browse Full Market Research Report On Antidiabetics Market @ http://bit.ly/2zArLIV Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/504https://www.gminsights.com/request-sample/detail/49

  6. 360° Analysis • Product Analysis • Insulin products accounted for largest market share in 2016 and is anticipated to expand at approximately 12.0% CAGR over the coming years. Major dominant players are developing innovative products used to treat and prevent the disease owing to increased burden of diabetes. • Regional Analysis • U.S. antidiabetics market accounted for largest regional share in 2016 owing to high prevalence of diabetes in the country. Germany antidiabetics market will witness a robust growth over the forecast period due to rising prevalence of type II diabetes which further results to increased usage rate of antidiabetics in the country. Asia Pacific should witness lucrative growth over the forecast timeframe owing to the presence of large patient pool in India and China. • Competitive Market Share • Some of the major players dominating global antidiabetics market are Novo Nordisk, Eli Lilly and Sanofi. Other active players in the market include Takeda Pharmaceuticals, Merck, Boehringer Ingelheim and Bristol-Myers Squibb.

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related